This difference in the number of MYCN‐amplified retinoblastomas carrying two, one, or zero RB1 mutations (eight, four, and six, respectively) compared to MYCN‐low tumors (195, 25, and seven, respectively) was significant (P < 0.001, Table 1). Here, RB1 is linked to retinoblastoma.